Lambrolizumab

Product Description

Product	Lambrolizumab
CAS	1374853-91-4
Formula	C₆₅₀₄-H₁₀₀₀₄-N₁₇₁₆-O₂₀₃₆-S₄₆
Synonym	Immunoglobulin G4, anti-(human protein PDCD1 (programmed cell death 1)) (human-Mus musculus monoclonal heavy chain), disulfide with human-Mus musculus monoclonal light chain, dimer, Lambrolizumab, UNII-DPT0O3T46P, Immunoglobulin G4, anti-(human programmed cell death 1), humanized mouse monoclonal (228-L-proline(H10-S>P))gamma 4 heavy chain (134-218&#039, )-disulfide with humanized mouse monoclonal kappa light chain dimer (226-226&#039, &#039, :229-229&#039, &#039, )- bisdisulfide

Assay/Purity	Typically NLT 98%
Chemical Structure
Notes	Lambrolizumab is classified as an: Active Pharmaceutical Ingredient (API) / Pharmaceutical Intermediate
Class	Active Pharmaceutical Ingredients (API) & Intermediates, API Product List
Industry	Pharmaceutical

Enter a chemical name, synonym or CAS# below